Mitochondrial oxidation of 4-hydroxy-2-nonenal in rat cerebral cortex

Journal of Neurochemistry

Volumn 84, Issue 6, 2003, Pages 1313-1321

  Murphy, Tonya C ^a   Amarnath, Venkataraman ^b   Picklo Sr , Matthew J ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

4 Hydroxynonenal; Aldehyde dehydrogenase; Alzheimer's disease; Mitochondria

Indexed keywords

4 HYDROXY 2 NONENOATE; 4 HYDROXYNONENAL; CARBOXYLIC ACID; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN CORTEX; BRAIN SLICE; CELL LINE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DETOXIFICATION; DOSE RESPONSE; HOMOGENATE; INTRACELLULAR SPACE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; RAT;

ALDEHYDES; ANIMALS; BIOLOGICAL MARKERS; CELL LINE; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROXY ACIDS; MALE; MITOCHONDRIA; NEUROBLASTOMA; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; SUBCELLULAR FRACTIONS;

ANIMALIA;

EID: 0037347447     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01628.x     Document Type: Article

References (43)

1. Alary J., Debrauwer L., Fernandez Y., Paris A., Cravedi J. P., Dolo L., Rao D. and Bories G. (1998) Identification of novel urinary metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in rats. Chem. Res. Toxicol. 11, 1368-1376.
2. Amarnath V., Valentine W. M., Montine T. J., Patterson W. H., Amarnath K., Bassett C. N. and Graham D. G. (1998) Reactions of 4-hydroxy-2(E)-nonenal and related aldehydes with proteins studied by carbon-13 nuclear magnetic resonance spectroscopy. Chem. Res. Toxicol. 11, 317-328.
3. Bergmeyer H. and Bernt E. (1974) UV-assay with pyruvate and NADH, in Methods of Enzymatic Analysis, Vol. 2 (Bergmeyer H. U., ed.), pp. 574-578. Harcourt Brace Jovanovich, New York.
4. Chen J. J. and YuB. P. (1996) Detoxification of reactive aldehydes in mitochondria: effects of age and dietary restriction. Aging (Milano) 8, 334-340.
5. Cheng J. Z., Yang Y., Singh S. P., Singhal S. S., Awasthi S., Pan S. S., Singh S. V., Zimniak P. and Awasthi Y. C. (2001) Two distinct 4-hydroxynonenal metabolizing glutathione S-transferase isozymes are differentially expressed in human tissues. Biochem. Biophys. Res. Commun. 282, 1268-1274.
6. Cinti D. L., Keyes S. R., Lemelin M. A., Denk H. and Schenkman J. B. (1976) Biochemical properties of rat liver mitochondrial aldehyde dehydrogenase with respect to oxidation of formaldehyde. J. Biol. Chem. 251, 1571-1577.
7. Esterbauer H., Zollner H. and Lang J. (1985) Metabolism of the lipid peroxidation product 4-hydroxynonenal by isolated hepatocytes and by liver cytosolic fractions. Biochem. J. 228, 363-373.
8. Esterbauer H., Schaur R. and Zollner H. (1991) Chemistry and Biochemistry of 4-hydroxynonenal, malondialdehyde, and related aldehydes. Free Radic. Biol. Med. 11, 81-128.
9. Hubatsch I., Ridderstrom M. and Mannervik B. (1998) Human glutathione transferase A4-4: an alpha class enzyme with high catalytic efficiency in the conjugation of 4-hydroxynonenal and other genotoxic products of lipid peroxidation. Biochem. J. 330, 175-179.
10. Kamino K., Nagasaka K., Imagawa M., Yamamoto H., Yoneda H., Ueki A., Kitamura S., Namekata K., Miki T. and Ohta S. (2000) Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population. Biochem. Biophys. Res. Commun. 273, 192-196.
11. Keller J. N., Pang Z., Geddes J. W., Begley J. G., Germeyer A., Waeg G. and Mattson M. P. (1997) Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69, 273-284.
12. Koivula T., Turner A. J., Huttunen M. and Koivusalo M. (1981) Sub-cellular and perisynaptic distribution of rat brain aldehyde dehydrogenase activity. J. Neurochem. 36, 1893-1897.
13. Laurent A., Perdu-Durand E., Alary J., Debrauwer L. and Cravedi J. P. (2000) Metabolism of 4-hydroxynonenal, a cytotoxic product of lipid peroxidation, in rat precision-cut liver slices. Toxicol. Lett. 114, 203-214.
14. Lovell M. A., Ehmann W. D., Mattson M. P. and Markesbery W. R. (1997) Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging 18, 457-461.
15. McKracken E., Graham D. I., Nilsen M., Stewart J., Nicoll J. A. and Horsburgh K. (2001) 4-Hydroxynonenal immunoreactivity is increased in human hippocampus after global ischemia. Brain Pathol. 11, 414-421.
16. Mitchell D. and Petersen D. (1987) The oxidation of a,b,unsaturated aldehydic products in lipid peroxidation by rat liver aldehyde dehydrogenases. Toxicol. Appl. Pharmacol. 87, 403-410.
17. Montine K. S., Kim P. J., Olson S. J., Markesbery W. R. and Montine T. J. (1997) 4-Hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease. J. Neuropathol. Exp. Neurol. 56, 866-871.
18. Mosmann T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
19. Nadkarni D. V. and Sayre L. M. (1995) Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal. Chem. Res. Toxicol. 8, 284-291.
20. Nanduri B., Hayden J., Awasthi Y. and Zimniak P. (1996) Amino acid residue 104 in an a-class gluthione S-transferase is essential for the high selectivity of the enzyme for 4-hydroxynonenal. Arch. Biochem. Biophys. 335, 305-310.
21. Neely M. D., Sidell K. R., Graham D. G. and Montine T. J. (1999) The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin. J. Neurochem. 72, 2323-2333.
22. Neely M. D., Zimmerman L., Picklo M. J., Ou J. J., Morales C. R., Montine K. S., Amaranth V. and Montine T. J. (2000) Congeners of N (alpha)-acetyl-L-cysteine but not aminoguanidine act as neuroprotectants from the lipid peroxidation product 4-hydroxy-2-non-enal. Free Radic. Biol. Med. 29, 1028-1036.
23. O'Connor T., Ireland L. S., Harrison D. J. and Hayes J. D. (1999) Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. Biochem. J. 343, 487-504.
24. Pettersson H. and Tottmar O. (1982) Aldehyde dehydrogenases in rat brain. Subcellular distribution and properties. J. Neurochem. 38, 477-487.
25. Phillips A. and Langdon R. (1962) Hepatic triphosphopyridine nucleotide-cytochrome c reductase, isolation, characterization, and kinetic studies. J. Biol. Chem. 237, 2652-2660.
26. Picklo M. J. and Montine T. J. (2001) Acrolein inhibits respiration in isolated brain mitochondria. Biochim. Biophys. Acta 1535, 145-152.
27. Picklo M. J., Amarnath V., McIntyre J. O., Graham D. G. and Montine T. J. (1999) 4-Hydroxy-2(E)-nonenal inhibits CNS mitochondrial respiration at multiple sites. J. Neurochem. 72, 1617-1624.
28. Picklo M., Olson S., Markesbery W. and Montine T. (2001) Expression and activities of aldo-keto oxidoreductases in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 60, 686-695.
29. Picklo M., Montine T., Amaranth V. and Neely M. D. (2002) Carbonyl toxicology and Alzheimer's disease. Toxicol. Appl. Pharmacol. 184, 187-197.
30. Radi R., Castro L., Rodriguez M., Cassina A. and Thomson L. (1997) Free radical damage to mitochondria, in Mitochondria and Free Radicals in Neurodegenerative Diseases (Bodis-Wollner I., ed.), pp. 57-89. Wiley-Liss, New York.
31. Rosenthal R., Hamud F., Fiskum G., Varghese P. and Sharpe S. (1987) Cerebral ischemia and reperfusion: prevention of brain mitochondrial injury by lidoflazine. J. Cereb. Blood Flow Metab. 7, 752-758.
32. Ryzlak M. and Pietruszko R. (1989) Human brain glyceraldehyde-3-phosphate dehydrogenase, succinic semialdehyde dehydrogenase and aldehyde dehydrogenase isozymes: substrate specificity and sensitivity to disulfiram. Alcoholism Clin. Exp. Res. 13, 755-761.
33. Sayre L. M., Arora P. K., Iyer R. S. and Salomon R. G. (1993) Pyrrole formation from 4-hydroxynonenal and primary amines. Chem. Res. Toxicol. 6, 19-22.
34. Sayre L. M., Zelasko D. A., Harris P. L., Perry G., Salomon R. G. and Smith M. A. (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68, 2092-2097.
35. Selley M. (1998) (E)-4-Hydroxynonenal may be involved in the pathogenesis of Parkinson's disease. Free Radic. Biol. Med. 25, 169-174.
36. Srivastava S., Chandra A., Wang L. F., Seifert W. E. Jr, DaGue B. B., Ansari N. H., Srivastava S. K. and Bhatnagar A. (1998) Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart. J. Biol. Chem. 273, 10893-10900.
37. Srivatava S., Watowich S. J., Petrash J. M., Srivatava S. K. and Bhatanagar A. (1999) Structural and kinetic determinants of aldehyde reduction by aldose reductase. Biochemistry 38, 42-54.
38. Staub R. E., Sparks S. E., Quistad G. B. and Casida J. E. (1995) S-methylation as a bioactivation mechanism for mono- and dithiocarbamate pesticides as aldehyde dehydrogenase inhibitors. Chem. Res. Toxicol. 8, 1063-1069.
39. Townsend A. J., Leone-Kabler S., Haynes R. L., Wu Y., Szweda L. and Bunting K. D. (2001) Selective protection by stably transfected human ALDH3A1 (but not human ALDH1A1) against toxicity of aliphatic aldehydes in V79 cells. Chem. Biol. Interact. 130-132, 261-273.
40. Ullrich O., Grune T., Henke W., Esterbauer H. and Siems W. G. (1994) Identification of metabolic pathways of the lipid peroxidation product 4-hydroxynonenal by mitochondria isolated from rat kidney cortex. FEBS Lett. 352, 84-86.
41. Weiner H. and Ardelt B. (1984) Ditribution and properties of aldehdye dehydrogenase in regions of rat brain. J. Neurochem. 42, 109-115.
42. Xu G., Liu Y., Kansal M. M. and Sayre L. M. (1999) Rapid cross-linking of proteins by 4-ketoaldehydes and 4-hydroxy-2-alkenals does not arise from the lysine-derived monoalkylpyrroles. Chem. Res. Toxicol. 12, 855-861.
43. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E. R. and Mizuno Y. (1996) Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl Acad. Sci. USA 93, 2696-2701.